Dividend Investing Ideas Center
Have you ever wished for the safety of bonds, but the return potential...
Before the opening bell on Tuesday, a number of big name, dividend paying companies announced their quarterly earnings. Below, we look at these earnings reports and break down the important points for investors.
Pfizer (PFE ) reported Q1 earnings of $2.38 billion, or 38 cents per share, up from $2.33 billion, or 36 cents per share, last year. Excluding special items, EPS was 51 cents per share—above analysts’ view of 49 cents.
Revenue dipped 4% to $10.86 billion from $11.35 billion. Analysts expected to see revenue of $10.72 billion.
Looking ahead, PFE expects to see EPS between $1.95 and $2.05. Analysts expect to see EPS of $2.07.
Merck (MRK ) reported first quarter earnings of $953 million, or 33 cents per share, down from $1.7 billion, or 57 cents per share, last year. Adjusted earnings were 85 cents per share—above analysts’ view of 74 cents per share.
Revenue was $9.42 billion from $10.26 billion last year. Analysts expected to see $8.99 billion in revenue.
Bristol-Myers Squibb (BMY ) reported Q1 earnings of $1.2 billion, or 71 cents per share, up from $937 million, or 56 cents per share, last year. Adjusted EPS came in at $1.2 billion, or 71 cents—well above analysts’ estimate of 50 cents.
Revenue increased 6% to $4.0 billion. Analysts expected to see revenue of $3.80 billion.
United Parcel Service (UPS ) reported first quarter earnings of $1.026 billion, or $1.12 per share, up from $911 million, or 98 cents per share, a year ago. On average, analysts expected to see EPS of $1.09.
Revenue grew 14% to $14.0 billion. Analysts expected to see revenue of $14.27 billion.